Fundraising Fox

Neuraltus Pharmaceuticals

San Bruno, US · Delaware corporation

Biotech

Founders & leadership

JW
John WhelanExecutive
RC
Richard CaseyExecutive

Board

AB
Annette BianchiBoard director
JW
James WoodyBoard director
DM
Donald McGovernBoard director

Reported raises · per SEC filings

Form D private placements

$14.9M disclosed across 1 round · 2016

▶$14.9MraisedMay 2016 · 4 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • James WoodyDirector
  • Donald McGovernDirector
  • Annette BianchiDirector
  • John WhelanExecutive Officer
  • Richard CaseyExecutive Officer, Director
Offering amount
$21.9M
Amount sold
$14.9M
First sale
May 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Neuraltus Pharmaceuticals Provides Enrollment Update on Confirmatory Phase 2 Study of NP001 in ALSprnewswire.com · Feb 2017Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001prnewswire.com · Jul 2015Drug Developer Neuraltus Pharmaceuticals, Inc. Raises $9.6 Million Toward $11 Million Goal - BioSpacebiospace.com · Dec 2011Neuraltus Pharma Raises $17 Million | Fierce Biotechfiercebiotech.com · Mar 2009

Frequently asked questions

How much funding has Neuraltus Pharmaceuticals raised?
Neuraltus Pharmaceuticals has disclosed $14.9M raised across 1 round.
Where is Neuraltus Pharmaceuticals headquartered?
Neuraltus Pharmaceuticals is headquartered in San Bruno, US.